The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

✍ Scribed by Müller, N; Schwarz, M J; Dehning, S; Douhe, A; Cerovecki, A; Goldstein-Müller, B; Spellmann, I; Hetzel, G; Maino, K; Kleindienst, N

• Book ID: 110060083
• Publisher: Nature Publishing Group
• Year: 2006
• Tongue: English
• Weight: 96 KB
• Volume: 11
• Category: Article
• ISSN: 1359-4184
• DOI: 10.1038/sj.mp.4001805